The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Multi-use Capsule-based Dry Powder Inhaler Market Research Report 2025

Global Multi-use Capsule-based Dry Powder Inhaler Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1885700

No of Pages : 98

Ask Your Query
Synopsis
The global Multi-use Capsule-based Dry Powder Inhaler market was valued at US$ 435.8 million in 2023 and is anticipated to reach US$ 599.6 million by 2030, witnessing a CAGR of 4.7% during the forecast period 2024-2030.
The Multi-use Capsule-based Dry Powder Inhaler market is evolving positively, driven by several key factors. These inhalers offer a convenient and versatile option for administering medications, especially for patients with respiratory conditions like asthma and COPD. The flexibility to use various medications in the form of capsules within a single inhaler device contributes to their appeal among patients and healthcare providers. The market's growth is further fueled by technological advancements enhancing inhaler design, dose accuracy, and improved drug delivery, providing customized treatment options. Additionally, the rising prevalence of respiratory disorders globally has heightened the demand for effective inhaler devices. However, hindrances include regulatory complexities surrounding the approval and standardization of multi-use capsule-based inhalers, ensuring their safety, efficacy, and interoperability. Moreover, challenges related to the cost of development, manufacturing, and access to these advanced inhalers may restrict market penetration. Nevertheless, with continued research and development, along with increasing acceptance of innovative inhaler technologies, the Multi-use Capsule-based Dry Powder Inhaler market is poised for sustained growth, offering improved therapeutic options and patient convenience.
This report aims to provide a comprehensive presentation of the global market for Multi-use Capsule-based Dry Powder Inhaler, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multi-use Capsule-based Dry Powder Inhaler.
Report Scope
The Multi-use Capsule-based Dry Powder Inhaler market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Multi-use Capsule-based Dry Powder Inhaler market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Multi-use Capsule-based Dry Powder Inhaler manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
3M
AstraZeneca
Chiesi Farmaceutici
Hovione
MannKind
Viatris
Iconovo
Changzhou DSB Medical
Boehringer Ingelheim
Cipla
Novartis Pharmaceuticals
Merck
Sumitomo Pharma America
Eskayef Pharmaceuticals
PharmEvo
Getz Pharma
Suzhou Inhal Pharma
Segment by Type
Single Dose
Multi Dose
Segment by Application
Asthma
Anti-infective
Rescue
Vaccine
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Multi-use Capsule-based Dry Powder Inhaler manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Multi-use Capsule-based Dry Powder Inhaler in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Multi-use Capsule-based Dry Powder Inhaler Market Overview
1.1 Product Overview and Scope of Multi-use Capsule-based Dry Powder Inhaler
1.2 Multi-use Capsule-based Dry Powder Inhaler Segment by Type
1.2.1 Global Multi-use Capsule-based Dry Powder Inhaler Market Value Comparison by Type (2024-2030)
1.2.2 Single Dose
1.2.3 Multi Dose
1.3 Multi-use Capsule-based Dry Powder Inhaler Segment by Application
1.3.1 Global Multi-use Capsule-based Dry Powder Inhaler Market Value by Application: (2024-2030)
1.3.2 Asthma
1.3.3 Anti-infective
1.3.4 Rescue
1.3.5 Vaccine
1.3.6 Others
1.4 Global Multi-use Capsule-based Dry Powder Inhaler Market Size Estimates and Forecasts
1.4.1 Global Multi-use Capsule-based Dry Powder Inhaler Revenue 2019-2030
1.4.2 Global Multi-use Capsule-based Dry Powder Inhaler Sales 2019-2030
1.4.3 Global Multi-use Capsule-based Dry Powder Inhaler Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Multi-use Capsule-based Dry Powder Inhaler Market Competition by Manufacturers
2.1 Global Multi-use Capsule-based Dry Powder Inhaler Sales Market Share by Manufacturers (2019-2024)
2.2 Global Multi-use Capsule-based Dry Powder Inhaler Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Multi-use Capsule-based Dry Powder Inhaler Average Price by Manufacturers (2019-2024)
2.4 Global Multi-use Capsule-based Dry Powder Inhaler Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Multi-use Capsule-based Dry Powder Inhaler, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Multi-use Capsule-based Dry Powder Inhaler, Product Type & Application
2.7 Multi-use Capsule-based Dry Powder Inhaler Market Competitive Situation and Trends
2.7.1 Multi-use Capsule-based Dry Powder Inhaler Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Multi-use Capsule-based Dry Powder Inhaler Players Market Share by Revenue
2.7.3 Global Multi-use Capsule-based Dry Powder Inhaler Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Multi-use Capsule-based Dry Powder Inhaler Retrospective Market Scenario by Region
3.1 Global Multi-use Capsule-based Dry Powder Inhaler Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Multi-use Capsule-based Dry Powder Inhaler Global Multi-use Capsule-based Dry Powder Inhaler Sales by Region: 2019-2030
3.2.1 Global Multi-use Capsule-based Dry Powder Inhaler Sales by Region: 2019-2024
3.2.2 Global Multi-use Capsule-based Dry Powder Inhaler Sales by Region: 2025-2030
3.3 Global Multi-use Capsule-based Dry Powder Inhaler Global Multi-use Capsule-based Dry Powder Inhaler Revenue by Region: 2019-2030
3.3.1 Global Multi-use Capsule-based Dry Powder Inhaler Revenue by Region: 2019-2024
3.3.2 Global Multi-use Capsule-based Dry Powder Inhaler Revenue by Region: 2025-2030
3.4 North America Multi-use Capsule-based Dry Powder Inhaler Market Facts & Figures by Country
3.4.1 North America Multi-use Capsule-based Dry Powder Inhaler Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Multi-use Capsule-based Dry Powder Inhaler Sales by Country (2019-2030)
3.4.3 North America Multi-use Capsule-based Dry Powder Inhaler Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Multi-use Capsule-based Dry Powder Inhaler Market Facts & Figures by Country
3.5.1 Europe Multi-use Capsule-based Dry Powder Inhaler Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Multi-use Capsule-based Dry Powder Inhaler Sales by Country (2019-2030)
3.5.3 Europe Multi-use Capsule-based Dry Powder Inhaler Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Multi-use Capsule-based Dry Powder Inhaler Market Facts & Figures by Country
3.6.1 Asia Pacific Multi-use Capsule-based Dry Powder Inhaler Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Multi-use Capsule-based Dry Powder Inhaler Sales by Country (2019-2030)
3.6.3 Asia Pacific Multi-use Capsule-based Dry Powder Inhaler Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Multi-use Capsule-based Dry Powder Inhaler Market Facts & Figures by Country
3.7.1 Latin America Multi-use Capsule-based Dry Powder Inhaler Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Multi-use Capsule-based Dry Powder Inhaler Sales by Country (2019-2030)
3.7.3 Latin America Multi-use Capsule-based Dry Powder Inhaler Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Multi-use Capsule-based Dry Powder Inhaler Market Facts & Figures by Country
3.8.1 Middle East and Africa Multi-use Capsule-based Dry Powder Inhaler Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Multi-use Capsule-based Dry Powder Inhaler Sales by Country (2019-2030)
3.8.3 Middle East and Africa Multi-use Capsule-based Dry Powder Inhaler Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Multi-use Capsule-based Dry Powder Inhaler Sales by Type (2019-2030)
4.1.1 Global Multi-use Capsule-based Dry Powder Inhaler Sales by Type (2019-2024)
4.1.2 Global Multi-use Capsule-based Dry Powder Inhaler Sales by Type (2025-2030)
4.1.3 Global Multi-use Capsule-based Dry Powder Inhaler Sales Market Share by Type (2019-2030)
4.2 Global Multi-use Capsule-based Dry Powder Inhaler Revenue by Type (2019-2030)
4.2.1 Global Multi-use Capsule-based Dry Powder Inhaler Revenue by Type (2019-2024)
4.2.2 Global Multi-use Capsule-based Dry Powder Inhaler Revenue by Type (2025-2030)
4.2.3 Global Multi-use Capsule-based Dry Powder Inhaler Revenue Market Share by Type (2019-2030)
4.3 Global Multi-use Capsule-based Dry Powder Inhaler Price by Type (2019-2030)
5 Segment by Application
5.1 Global Multi-use Capsule-based Dry Powder Inhaler Sales by Application (2019-2030)
5.1.1 Global Multi-use Capsule-based Dry Powder Inhaler Sales by Application (2019-2024)
5.1.2 Global Multi-use Capsule-based Dry Powder Inhaler Sales by Application (2025-2030)
5.1.3 Global Multi-use Capsule-based Dry Powder Inhaler Sales Market Share by Application (2019-2030)
5.2 Global Multi-use Capsule-based Dry Powder Inhaler Revenue by Application (2019-2030)
5.2.1 Global Multi-use Capsule-based Dry Powder Inhaler Revenue by Application (2019-2024)
5.2.2 Global Multi-use Capsule-based Dry Powder Inhaler Revenue by Application (2025-2030)
5.2.3 Global Multi-use Capsule-based Dry Powder Inhaler Revenue Market Share by Application (2019-2030)
5.3 Global Multi-use Capsule-based Dry Powder Inhaler Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Multi-use Capsule-based Dry Powder Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Multi-use Capsule-based Dry Powder Inhaler Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 3M
6.2.1 3M Corporation Information
6.2.2 3M Description and Business Overview
6.2.3 3M Multi-use Capsule-based Dry Powder Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.2.4 3M Multi-use Capsule-based Dry Powder Inhaler Product Portfolio
6.2.5 3M Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Corporation Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca Multi-use Capsule-based Dry Powder Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.3.4 AstraZeneca Multi-use Capsule-based Dry Powder Inhaler Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Chiesi Farmaceutici
6.4.1 Chiesi Farmaceutici Corporation Information
6.4.2 Chiesi Farmaceutici Description and Business Overview
6.4.3 Chiesi Farmaceutici Multi-use Capsule-based Dry Powder Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Chiesi Farmaceutici Multi-use Capsule-based Dry Powder Inhaler Product Portfolio
6.4.5 Chiesi Farmaceutici Recent Developments/Updates
6.5 Hovione
6.5.1 Hovione Corporation Information
6.5.2 Hovione Description and Business Overview
6.5.3 Hovione Multi-use Capsule-based Dry Powder Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hovione Multi-use Capsule-based Dry Powder Inhaler Product Portfolio
6.5.5 Hovione Recent Developments/Updates
6.6 MannKind
6.6.1 MannKind Corporation Information
6.6.2 MannKind Description and Business Overview
6.6.3 MannKind Multi-use Capsule-based Dry Powder Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.6.4 MannKind Multi-use Capsule-based Dry Powder Inhaler Product Portfolio
6.6.5 MannKind Recent Developments/Updates
6.7 Viatris
6.6.1 Viatris Corporation Information
6.6.2 Viatris Description and Business Overview
6.6.3 Viatris Multi-use Capsule-based Dry Powder Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Viatris Multi-use Capsule-based Dry Powder Inhaler Product Portfolio
6.7.5 Viatris Recent Developments/Updates
6.8 Iconovo
6.8.1 Iconovo Corporation Information
6.8.2 Iconovo Description and Business Overview
6.8.3 Iconovo Multi-use Capsule-based Dry Powder Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Iconovo Multi-use Capsule-based Dry Powder Inhaler Product Portfolio
6.8.5 Iconovo Recent Developments/Updates
6.9 Changzhou DSB Medical
6.9.1 Changzhou DSB Medical Corporation Information
6.9.2 Changzhou DSB Medical Description and Business Overview
6.9.3 Changzhou DSB Medical Multi-use Capsule-based Dry Powder Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Changzhou DSB Medical Multi-use Capsule-based Dry Powder Inhaler Product Portfolio
6.9.5 Changzhou DSB Medical Recent Developments/Updates
6.10 Boehringer Ingelheim
6.10.1 Boehringer Ingelheim Corporation Information
6.10.2 Boehringer Ingelheim Description and Business Overview
6.10.3 Boehringer Ingelheim Multi-use Capsule-based Dry Powder Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Boehringer Ingelheim Multi-use Capsule-based Dry Powder Inhaler Product Portfolio
6.10.5 Boehringer Ingelheim Recent Developments/Updates
6.11 Cipla
6.11.1 Cipla Corporation Information
6.11.2 Cipla Multi-use Capsule-based Dry Powder Inhaler Description and Business Overview
6.11.3 Cipla Multi-use Capsule-based Dry Powder Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Cipla Multi-use Capsule-based Dry Powder Inhaler Product Portfolio
6.11.5 Cipla Recent Developments/Updates
6.12 Novartis Pharmaceuticals
6.12.1 Novartis Pharmaceuticals Corporation Information
6.12.2 Novartis Pharmaceuticals Multi-use Capsule-based Dry Powder Inhaler Description and Business Overview
6.12.3 Novartis Pharmaceuticals Multi-use Capsule-based Dry Powder Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Novartis Pharmaceuticals Multi-use Capsule-based Dry Powder Inhaler Product Portfolio
6.12.5 Novartis Pharmaceuticals Recent Developments/Updates
6.13 Merck
6.13.1 Merck Corporation Information
6.13.2 Merck Multi-use Capsule-based Dry Powder Inhaler Description and Business Overview
6.13.3 Merck Multi-use Capsule-based Dry Powder Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Merck Multi-use Capsule-based Dry Powder Inhaler Product Portfolio
6.13.5 Merck Recent Developments/Updates
6.14 Sumitomo Pharma America
6.14.1 Sumitomo Pharma America Corporation Information
6.14.2 Sumitomo Pharma America Multi-use Capsule-based Dry Powder Inhaler Description and Business Overview
6.14.3 Sumitomo Pharma America Multi-use Capsule-based Dry Powder Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Sumitomo Pharma America Multi-use Capsule-based Dry Powder Inhaler Product Portfolio
6.14.5 Sumitomo Pharma America Recent Developments/Updates
6.15 Eskayef Pharmaceuticals
6.15.1 Eskayef Pharmaceuticals Corporation Information
6.15.2 Eskayef Pharmaceuticals Multi-use Capsule-based Dry Powder Inhaler Description and Business Overview
6.15.3 Eskayef Pharmaceuticals Multi-use Capsule-based Dry Powder Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Eskayef Pharmaceuticals Multi-use Capsule-based Dry Powder Inhaler Product Portfolio
6.15.5 Eskayef Pharmaceuticals Recent Developments/Updates
6.16 PharmEvo
6.16.1 PharmEvo Corporation Information
6.16.2 PharmEvo Multi-use Capsule-based Dry Powder Inhaler Description and Business Overview
6.16.3 PharmEvo Multi-use Capsule-based Dry Powder Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.16.4 PharmEvo Multi-use Capsule-based Dry Powder Inhaler Product Portfolio
6.16.5 PharmEvo Recent Developments/Updates
6.17 Getz Pharma
6.17.1 Getz Pharma Corporation Information
6.17.2 Getz Pharma Multi-use Capsule-based Dry Powder Inhaler Description and Business Overview
6.17.3 Getz Pharma Multi-use Capsule-based Dry Powder Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Getz Pharma Multi-use Capsule-based Dry Powder Inhaler Product Portfolio
6.17.5 Getz Pharma Recent Developments/Updates
6.18 Suzhou Inhal Pharma
6.18.1 Suzhou Inhal Pharma Corporation Information
6.18.2 Suzhou Inhal Pharma Multi-use Capsule-based Dry Powder Inhaler Description and Business Overview
6.18.3 Suzhou Inhal Pharma Multi-use Capsule-based Dry Powder Inhaler Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Suzhou Inhal Pharma Multi-use Capsule-based Dry Powder Inhaler Product Portfolio
6.18.5 Suzhou Inhal Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Multi-use Capsule-based Dry Powder Inhaler Industry Chain Analysis
7.2 Multi-use Capsule-based Dry Powder Inhaler Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Multi-use Capsule-based Dry Powder Inhaler Production Mode & Process
7.4 Multi-use Capsule-based Dry Powder Inhaler Sales and Marketing
7.4.1 Multi-use Capsule-based Dry Powder Inhaler Sales Channels
7.4.2 Multi-use Capsule-based Dry Powder Inhaler Distributors
7.5 Multi-use Capsule-based Dry Powder Inhaler Customers
8 Multi-use Capsule-based Dry Powder Inhaler Market Dynamics
8.1 Multi-use Capsule-based Dry Powder Inhaler Industry Trends
8.2 Multi-use Capsule-based Dry Powder Inhaler Market Drivers
8.3 Multi-use Capsule-based Dry Powder Inhaler Market Challenges
8.4 Multi-use Capsule-based Dry Powder Inhaler Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock